Provided by Tiger Trade Technology Pte. Ltd.

Nucana PLC

1.47
-0.0500-3.29%
Post-market: 1.470.00000.00%19:30 EDT
Volume:13.41K
Turnover:19.98K
Market Cap:6.12M
PE:-0.46
High:1.52
Open:1.52
Low:1.47
Close:1.52
52wk High:7.22
52wk Low:1.21
Shares:4.16M
Float Shares:4.16M
Volume Ratio:0.50
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1691
EPS(LYR):-17.5871
ROE:-70.26%
ROA:-43.49%
PB:0.22
PE(LYR):-0.08

Loading ...

European Equities Traded in the US as American Depositary Receipts Sharply Lower in Tuesday Trading

MT Newswires Live
·
Apr 21

European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

MT Newswires Live
·
Apr 20

European Equities Traded in the US as American Depositary Receipts Sharply Higher in Friday Trading

MT Newswires Live
·
Apr 17

European Equities Traded in the US as American Depositary Receipts Trending Lower in Wednesday Trading

MT Newswires Live
·
Apr 15

European Equities Traded in the US as ADRs Rise in Tuesday Trading

MT Newswires Live
·
Apr 14

European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading

MT Newswires Live
·
Apr 13

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live
·
Apr 09

European Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading

MT Newswires Live
·
Apr 07

NuCana files initial beneficial ownership statement for director Elliott Levy

Reuters
·
Apr 02

NuCana files Form 3 initial beneficial ownership statement for Head of Translational Medicine David Harrison

Reuters
·
Mar 25

NuCana plc director Martin C.B. Mellish files initial beneficial ownership statement

Reuters
·
Mar 21

NuCana plc files Form 3 initial beneficial ownership statement for Chief Medical Officer Jeffrey D. Bloss

Reuters
·
Mar 20

UK's NuCana Q4 net loss widens

Reuters
·
Mar 20

NuCana Q4 2025 EPS $0.00 and Revenue $0.00

Benzinga Earnings
·
Mar 20

NuCana FY 2025 net loss widens 54.7% to GBP 29.4 million, Q4 net loss rises more than doubled to GBP 2.5 million

Reuters
·
Mar 20

NuCana Plc - Final Data From Phase 2 Expansion Study of Nuc-7738 Expected in 2026

THOMSON REUTERS
·
Mar 20

NuCana: Plan to Obtain Regulatory Guidance From U.S. FDA Regarding Potential Registrational Pathway for Nuc-7738 in Melanoma

THOMSON REUTERS
·
Mar 20

Press Release: NuCana Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Business Update

Dow Jones
·
Mar 20

European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading

MT Newswires Live
·
Mar 19

NuCana plc files Form 3 initial beneficial ownership statement for Interim CFO Ian Alexander Webster

Reuters
·
Mar 19